Add like
Add dislike
Add to saved papers

Statistical efficiency of patient data in randomized clinical trials of epilepsy treatments.

Epilepsia 2020 July 14
OBJECTIVE: Previous research suggests that natural fluctuations in seizure rates within individuals have a quantifiable impact on therapeutic clinical trial outcomes.

METHODS: A trial simulator estimated the statistical power of clinical trials with a typical trial design with and without patients included who exhibited a range of means (1-15 seizures/mo) and standard deviations (1-15 seizures/mo) in their baseline seizure rates. Trial outcomes were evaluated using 50% responder rates, median percentage change, and time to prerandomization.

RESULTS: Patients with higher seizure frequencies and lower standard deviations during their baseline contribute more to the statistical power regardless of the method used to evaluate the trial. Power varied from -20% to 30% depending on baseline seizure characteristics.

SIGNIFICANCE: Patient-specific characteristics can predict the contributions to the statistical power of clinical trials for epilepsy treatments. It may be possible to characterize this contribution with baseline data, leading to more efficient clinical trials.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app